Endocrine receptors of the GPCR family are established targets in autoimmune diseases, with the receptor for thyrotropin (TSHR) taking center stage in autoimmune thyroid diseases, particularly Graves’ disease, where activating autoantibodies not only serve as diagnostic parameters but also represent the cause and a major therapeutic target of the disease [27]. The gene discussed is TSHR; the disease is Graves disease.